About Synvivia
Synvivia is a company based in Berkeley (United States) founded in 2015.. Synvivia has raised $174.1 thousand across 5 funding rounds from investors including HHS, America’s Seed Fund and Y Combinator. The company has 4 employees as of December 31, 2024. Synvivia operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Berkeley, United States
- Employees 4 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synvivia, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$174.1 K (USD)
in 5 rounds
-
Latest Funding Round
$1.64 M (USD), Grant
Dec 15, 2024
-
Investors
HHS
& 2 more
-
Employee Count
4
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Synvivia
Synvivia has successfully raised a total of $174.1K across 5 strategic funding rounds. The most recent funding activity was a Grant round of $1.64 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $1.6M
-
First Round
First Round
(01 Jun 2016)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Grant - Synvivia | Valuation |
investors |
|
| Dec, 2023 | Amount | Seed - Synvivia | Valuation |
investors |
|
| Dec, 2021 | Amount | Grant - Synvivia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Synvivia
Synvivia has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, America’s Seed Fund and Y Combinator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Synvivia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Synvivia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synvivia Comparisons
Competitors of Synvivia
Synvivia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Synvivia
When was Synvivia founded?
Synvivia was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Synvivia located?
Synvivia is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Is Synvivia a funded company?
Synvivia is a funded company, having raised a total of $174.1K across 5 funding rounds to date. The company's 1st funding round was a Grant of $255.91K, raised on Jun 01, 2016.
How many employees does Synvivia have?
As of Dec 31, 2024, the latest employee count at Synvivia is 4.
What does Synvivia do?
Synvivia was founded in 2015 in Berkeley, United States, as a biotechnology firm. Molecular switches are engineered to enable precise regulation of enzyme activity through small molecules. The platform is utilized to produce modified proteins applicable in biosensors, inducible gene expression systems, and process controls within fermentation and biomanufacturing operations. Additional uses in protein engineering and synthetic biology are explored.
Who are the top competitors of Synvivia?
Synvivia's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Synvivia's investors?
Synvivia has 3 investors. Key investors include HHS, America’s Seed Fund, and Y Combinator.